Correlation Between Dynavax Technologies and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Dynavax Technologies and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Regeneron Pharmaceuticals.
Diversification Opportunities for Dynavax Technologies and Regeneron Pharmaceuticals
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Dynavax and Regeneron is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dynavax Technologies and Regeneron Pharmaceuticals
Given the investment horizon of 90 days Dynavax Technologies is expected to generate 1.18 times more return on investment than Regeneron Pharmaceuticals. However, Dynavax Technologies is 1.18 times more volatile than Regeneron Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.27 per unit of risk. If you would invest 1,135 in Dynavax Technologies on November 1, 2024 and sell it today you would earn a total of 163.00 from holding Dynavax Technologies or generate 14.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dynavax Technologies vs. Regeneron Pharmaceuticals
Performance |
| Timeline |
| Dynavax Technologies |
| Regeneron Pharmaceuticals |
Dynavax Technologies and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dynavax Technologies and Regeneron Pharmaceuticals
The main advantage of trading using opposite Dynavax Technologies and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.| Dynavax Technologies vs. Alkermes Plc | Dynavax Technologies vs. Neurocrine Biosciences | Dynavax Technologies vs. Intracellular Th | Dynavax Technologies vs. Aquestive Therapeutics |
| Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |